Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to simplify heart monitoring for pump patients

NCT ID NCT04641416

Recruiting now Diagnosis Sponsor: Thomas Schlöglhofer, PhD, MSc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study explores whether data from the HeartMate 3 heart pump can be used to monitor heart function without invasive tests or frequent imaging. Researchers will compare high-resolution pump data with standard echocardiograms and ECGs in 60 patients with end-stage heart failure. If successful, this could lead to simpler, automatic monitoring for LVAD patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could allow doctors to monitor heart function in LVAD patients using only pump data, reducing the need for frequent ultrasounds and ECGs.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply to all patients. The new method may not be accurate enough to replace standard tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOMYOPATHIES END-STAGE HEART FAILURE MECHANICAL CIRCULATORY SUPPORT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical University of Vienna

    RECRUITING

    Vienna, 1090, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.